His primary areas of study are Genetics, Gene, Genome, Mutation and Germline mutation. Genomics, Carcinogenesis, MicroRNA sequencing, Exome and Genetic heterogeneity are the core of his Genetics study. Gene and Serous fluid are frequently intertwined in his study.
The various areas that he examines in his Mutation study include Leukemia and Myeloid leukemia. His biological study deals with issues like Cancer research, which deal with fields such as Serous carcinoma. As a part of the same scientific study, Michael D. McLellan usually deals with the Germline mutation, concentrating on Adenocarcinoma and frequently concerns with Exon and MLH1.
Genetics, Gene, Cancer research, Genome and Computational biology are his primary areas of study. His work in Genetics addresses subjects such as Myeloid leukemia, which are connected to disciplines such as Leukemia and Enasidenib. The study incorporates disciplines such as Cancer and Molecular biology in addition to Gene.
His Cancer research research is multidisciplinary, incorporating elements of KRAS, microRNA, Serous fluid and PTEN. In his study, Comparative genomic hybridization is inextricably linked to SNP array, which falls within the broad field of Genome. Michael D. McLellan studied Genomics and Exome that intersect with Genetic heterogeneity.
Michael D. McLellan focuses on Cancer research, Genetics, Computational biology, Germline mutation and Genome. His Cancer research research includes themes of Thymic carcinoma, Thymoma, microRNA and Oncogene. His Computational biology research incorporates elements of Exome sequencing, Exome and Hpv genotypes.
In his research on the topic of Germline mutation, Carcinogenesis, PALB2, Loss of heterozygosity, Genetic testing and Allele frequency is strongly related with Germline. His work deals with themes such as Gene duplication, Chromosome instability and Chromosome 3, which intersect with Genome. His study in Whole genome sequencing is interdisciplinary in nature, drawing from both Point mutation, Genomics, Chromothripsis, Exon and Massive parallel sequencing.
The scientist’s investigation covers issues in Cancer research, Germline mutation, Genomics, microRNA and Oncogene. His Cancer research research focuses on subjects like Transcription factor, which are linked to Non-coding RNA. His Germline mutation research is included under the broader classification of Genetics.
He integrates many fields, such as Genetics and SDHA, in his works. As a member of one scientific family, Michael D. McLellan mostly works in the field of Genomics, focusing on Computational biology and, on occasion, Exome sequencing and Exome. Michael D. McLellan has researched Oncogene in several fields, including Chromatin, PTEN, Carcinogenesis and Proto-Oncogene Proteins c-myc.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
Integrated genomic analyses of ovarian carcinoma
D. Bell;A. Berchuck;M. Birrer;J. Chien.
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael.
The New England Journal of Medicine (2013)
The cancer genome atlas pan-cancer analysis project
John N Weinstein;John N Weinstein;Eric A. Collisson;Gordon B Mills;Kenna R Mills Shaw;Kenna R Mills Shaw.
Nature Genetics (2013)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt;Qunyuan Zhang;David E. Larson;Dong Shen.
Genome Research (2012)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds.
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth;Michael D. McLellan;Fabio Vandin;Kai Ye.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Integrated genomic characterization of endometrial carcinoma
Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: